386 related articles for article (PubMed ID: 33843697)
1. Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.
Leta V; Urso D; Batzu L; Weintraub D; Titova N; Aarsland D; Martinez-Martin P; Borghammer P; van Wamelen DJ; Yousaf T; Rizos A; Rodriguez-Blazquez C; Chung-Faye G; Chaudhuri KR
J Parkinsons Dis; 2021; 11(3):1209-1219. PubMed ID: 33843697
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease.
Jones JD; Rahmani E; Garcia E; Jacobs JP
Parkinsonism Relat Disord; 2020 Mar; 72():7-12. PubMed ID: 32058266
[TBL] [Abstract][Full Text] [Related]
3. Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.
Liu G; Locascio JJ; Corvol JC; Boot B; Liao Z; Page K; Franco D; Burke K; Jansen IE; Trisini-Lipsanopoulos A; Winder-Rhodes S; Tanner CM; Lang AE; Eberly S; Elbaz A; Brice A; Mangone G; Ravina B; Shoulson I; Cormier-Dequaire F; Heutink P; van Hilten JJ; Barker RA; Williams-Gray CH; Marinus J; Scherzer CR; ; ; ; ; ; ;
Lancet Neurol; 2017 Aug; 16(8):620-629. PubMed ID: 28629879
[TBL] [Abstract][Full Text] [Related]
4. Baseline prevalence and longitudinal assessment of autonomic dysfunction in early Parkinson's disease.
Yang L; Gao H; Ye M
J Neural Transm (Vienna); 2024 Feb; 131(2):127-139. PubMed ID: 37923936
[TBL] [Abstract][Full Text] [Related]
5. Olfactory impairment predicts cognitive decline in early Parkinson's disease.
Fullard ME; Tran B; Xie SX; Toledo JB; Scordia C; Linder C; Purri R; Weintraub D; Duda JE; Chahine LM; Morley JF
Parkinsonism Relat Disord; 2016 Apr; 25():45-51. PubMed ID: 26923521
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with
Sheng ZH; Ma LZ; Liu JY; Ou YN; Zhao B; Ma YH; Tan L
Front Aging Neurosci; 2022; 14():1061096. PubMed ID: 36589544
[TBL] [Abstract][Full Text] [Related]
7. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group.
Santos García D; García Roca L; de Deus Fonticoba T; Cores Bartolomé C; Naya Ríos L; Canfield H; Paz González JM; Martínez Miró C; Jesús S; Aguilar M; Pastor P; Planellas L; Cosgaya M; García Caldentey J; Caballol N; Legarda I; Hernández Vara J; Cabo I; López Manzanares L; González Aramburu I; Ávila Rivera MA; Gómez Mayordomo V; Nogueira V; Puente V; Dotor García-Soto J; Borrué C; Solano Vila B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Carrillo Padilla F; Martínez Castrillo JC; Sánchez Alonso P; Alonso Losada MG; López Ariztegui N; Gastón I; Kulisevsky J; Blázquez Estrada M; Seijo M; Rúiz Martínez J; Valero C; Kurtis M; de Fábregues O; González Ardura J; Alonso Redondo R; Ordás C; López Díaz L LM; McAfee D; Martinez-Martin P; Mir P;
J Parkinsons Dis; 2022; 12(1):315-331. PubMed ID: 34602501
[TBL] [Abstract][Full Text] [Related]
8. Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.
Oikonomou P; van Wamelen DJ; Weintraub D; Aarsland D; Ffytche D; Martinez-Martin P; Rodriguez-Blazquez C; Leta V; Borley C; Sportelli C; Trivedi D; Podlewska AM; Rukavina K; Rizos A; Lazcano-Ocampo C; Ray Chaudhuri K
Brain Behav; 2021 May; 11(5):e02086. PubMed ID: 33645912
[TBL] [Abstract][Full Text] [Related]
9. REM sleep behavior disorder correlates with constipation in de novo Chinese Parkinson's disease patients.
Chen Y; Xu Q; Wu L; Zhou M; Lin Y; Jiang Y; He Q; Zhao L; Dong Y; Liu J; Chen W
Neurol Sci; 2023 Jan; 44(1):191-197. PubMed ID: 36098886
[TBL] [Abstract][Full Text] [Related]
10. Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson's disease.
Urso D; Leta V; Batzu L; Yousaf T; Farrell C; van Wamelen DJ; Ray Chaudhuri K
J Neurol; 2022 Mar; 269(3):1566-1573. PubMed ID: 34338858
[TBL] [Abstract][Full Text] [Related]
11. Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study.
Becker S; Bode M; Brockmann K; Gasser T; Michaelis K; Solbrig S; Nuerk HC; Schulte C; Maetzler W; Zimmermann M; Berg D; Liepelt-Scarfone I
Neurology; 2022 Dec; 99(23):e2548-e2560. PubMed ID: 36240089
[TBL] [Abstract][Full Text] [Related]
12. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort.
Jones JD; Kuhn TP; Szymkowicz SM
Parkinsonism Relat Disord; 2018 Feb; 47():3-7. PubMed ID: 29233608
[TBL] [Abstract][Full Text] [Related]
13. Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease.
Ma LZ; Zhang C; Wang H; Ma YH; Shen XN; Wang J; Tan L; Dong Q; Yu JT
J Parkinsons Dis; 2021; 11(3):1117-1127. PubMed ID: 33935105
[TBL] [Abstract][Full Text] [Related]
14. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease.
Sampedro F; Pérez-González R; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
Parkinsonism Relat Disord; 2020 May; 74():43-49. PubMed ID: 32334380
[TBL] [Abstract][Full Text] [Related]
15. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
16. The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study.
Stewart CB; Ledingham D; Foster VK; Anderson KN; Sathyanarayana S; Galley D; Pavese N; Pasquini J
Front Neurol; 2023; 14():1155669. PubMed ID: 37122303
[TBL] [Abstract][Full Text] [Related]
17. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
[TBL] [Abstract][Full Text] [Related]
18. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
[TBL] [Abstract][Full Text] [Related]
19. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment and dementia in young onset Parkinson's disease.
Santos-García D; de Deus Fonticoba T; Cores Bartolomé C; Feal Painceiras MJ; García Díaz I; Íñiguez Alvarado MC; Paz JM; Jesús S; Cosgaya M; García Caldentey J; Caballol N; Legarda I; Hernández Vara J; Cabo I; López Manzanares L; González Aramburu I; Ávila Rivera MA; Gómez Mayordomo V; Nogueira V; Dotor García-Soto J; Borrué C; Solano Vila B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Mendoza Z; Martínez Castrillo JC; Sánchez Alonso P; Alonso Losada MG; López Ariztegui N; Gastón I; Kulisevsky J; Seijo M; Valero C; Alonso Redondo R; Buongiorno MT; Ordás C; Menéndez-González M; McAfee D; Martinez-Martin P; Mir P;
J Neurol; 2023 Dec; 270(12):5793-5812. PubMed ID: 37578489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
